Cargando…

A multi‐omics perspective of CAR T cell therapy

As omics technologies, including genomics, epigenomics, transcriptomics, T cell receptor‐repertorie profiling, proteomics, metabolomics and microbiomics, have provided valuable insights into CAR T cell therapy, in our recent review, we discuss these multidimensional profiling technologies in CAR T c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Jingwen, Chen, Yamei, Han, Leng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10212274/ https://www.ncbi.nlm.nih.gov/pubmed/37228183 http://dx.doi.org/10.1002/ctm2.1274

Ejemplares similares

Dynamic fine-tuning of CAR-T cell therapy
por: Trehin, Pierre V.M., et al.
Publicado: (2023)

CAR-T cell therapy in myeloma: hopes and hurdles
por: Harousseau, Jean Luc
Publicado: (2023)

Modelling CAR-T therapy in humanized mice
por: Wu, Yongxia, et al.
Publicado: (2019)

Multi-omic Characterization of Intraspecies Variation in Laboratory and Natural Environments
por: Behringer, Megan G.
Publicado: (2021)

Multi-omics in COVID-19: Seeing the unseen but overlooked in the clinic
por: Lu, Tian, et al.
Publicado: (2022)

Price and Prejudice? The Value of Chimeric Antigen Receptor (CAR) T-Cell Therapy
por: Choi, Gyeyoung, et al.
Publicado: (2022)

Exposure assessment in early life: it is about time for multi-omics approaches
por: Goerdten, Jantje, et al.
Publicado: (2021)

Integrated Multi-Omics Perspective to Strengthen the Understanding of Salt Tolerance in Rice
por: Dai, Liping, et al.
Publicado: (2022)

The founding charter of the Omic Biodiversity Observation Network (Omic BON)
por: Meyer, Raïssa, et al.
Publicado: (2023)

CanDIG: Federated network across Canada for multi-omic and health data discovery and analysis
por: Dursi, L. Jonathan, et al.
Publicado: (2021)

CAR‐T cell therapy for lung cancer: Potential and perspective
por: Chen, Long, et al.
Publicado: (2022)

Buckling up against COVID-19 after CAR T-cell therapy
por: Auletta, Jeffery J.
Publicado: (2022)

The race is on: bispecifics vs CAR T cells in B-cell lymphoma
por: Gurumurthi, Ashwath, et al.
Publicado: (2023)

Pharmaco-omics data sheds light on therapy-oriented prospects of precision medicine
por: Zheng, Jie, et al.
Publicado: (2021)

A Review of Two Regulatory Approved Anti-CD19 CAR T-Cell Therapies in Diffuse Large B-Cell Lymphoma: Why Are Indirect Treatment Comparisons Not Feasible?
por: Zhang, Jie, et al.
Publicado: (2020)

Current status and perspective of CAR-T and CAR-NK cell therapy trials in Germany
por: Albinger, Nawid, et al.
Publicado: (2021)

Cars, CONSORT 2010, and Clinical Practice
por: Williams, Hywel C
Publicado: (2010)

CAR-macrophage: An extensive immune enhancer to fight cancer
por: Wang, Shuhang, et al.
Publicado: (2022)

A brief perspective on neural cell therapy
por: Pruszak, Jan
Publicado: (2014)

Role of artificial intelligence in integrated analysis of multi-omics and imaging data in cancer research
por: Phan, Nam Nhut, et al.
Publicado: (2019)

Frontal predominant encephalopathy with early paligraphia as a distinctive signature of CAR T-cell therapy-related neurotoxicity
por: Pensato, Umberto, et al.
Publicado: (2021)

Increase of diesel car raises health risk in spite of recent development in engine technology
por: Leem, Jong Han, et al.
Publicado: (2014)

Integrative Omics for Identifying Dysfunctional Pathways in CKD
por: Tin, Adrienne, et al.
Publicado: (2018)

Chimeric miRNA cluster enables multiplex and titratable gene inhibition in CAR-T cells
por: Haraszti, Reka Agnes
Publicado: (2023)

Multi Targeted CAR-T Cell Therapies for B-Cell Malignancies
por: Shah, Nirav N., et al.
Publicado: (2019)

Perspectives on the Evolution of Stem Cell Therapy for Heart Failure
por: Tompkins, Bryon, et al.
Publicado: (2015)

Overcoming acquired chemo-resistance to gemcitabine: implications from the perspective of multi-modal therapy including surgery for pancreatic cancer
por: Motoi, Fuyuhiko
Publicado: (2021)

Transplanters drive CARs to the clinic by brewing ICE-T: the Moffitt roadmap
por: Locke, Frederick L., et al.
Publicado: (2017)

Molecular pathological epidemiology: the role of epidemiology in the omics-era
por: Ikram, M. Arfan
Publicado: (2015)

Towards biome-specific analysis of meta-omics data
por: Darzi, Youssef, et al.
Publicado: (2016)

From spirometry to spatial omics in pursuit of asthma endotypes
por: Hinks, Timothy S. C.
Publicado: (2022)

Coping with COVID-19: Perspectives of Student Radiographers
por: Teo, Leng Woon, et al.
Publicado: (2020)

CAR-T Cells: Future Perspectives
por: Charrot, Sarah, et al.
Publicado: (2019)

TriKEs and BiKEs join CARs on the cancer immunotherapy highway
por: Tay, Szun Szun, et al.
Publicado: (2016)

New development in CAR-T cell therapy
por: Wang, Zhenguang, et al.
Publicado: (2017)

Keeping up with the ′omics: non-equilibrium models of gene regulation
por: Pincus, David
Publicado: (2015)

Going -omics to identify novel therapeutic targets for cardiovascular disease
por: Harber, Karl J., et al.
Publicado: (2019)

Living with Psoriasis Vulgaris and Multi-Treatment Failure: A Patient and Dermatologist Perspective
por: Spencer, Riley K., et al.
Publicado: (2023)

CD7 CAR: sword and shield
por: Velasquez, M. Paulina, et al.
Publicado: (2022)

Timing and regulation of hematopoietic stem cell colonization of the human fetal bone marrow by endothelial and CAR stromal cells during pregnancy
por: Lapidot, Tsvee
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_3cg34n86fkpv2f16quouq8bem2